Every trade that managers of Scope Fluidics S.A. disclose to KNF is tracked on this page. The company sits in the Health Care sector. In the past year (24 October 2025 to 24 October 2026), 5 filings came from 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of Scope Fluidics S.A. stock was filed. Typically, a trade is published a median of 2 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19).
With 5 filings in twelve months, the company is more active than the median of 3 filings across the 554 companies we follow on the same exchange.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from KNF. Past trades are no guide to future returns.
FY ended December 2025 · cache
5 of 5 declarations
Scope Fluidics S.A. is a company focused on developing innovative solutions for biotechnology and medical research. It is listed on the XWAR market.
Purchases our model currently ranks for the recommendations list.
All recommendations